跳至主要内容
临床试验/NCT01384110
NCT01384110已完成1 期

Efficacy of a Brown Seaweed Extract Rich in Polyphenols on Glycemic Response to Sucrose in Human

innoVactiv Inc.2 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2011年6月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
43
试验地点
2
主要终点
Significant reduction in postprandial glycemia

研究概览

简要总结

The primary endpoint of this trial will be to evaluate if a single administration in human of a lemon ice tea containing 500 mg of a polyphenol-rich algal powder is able to reduce postprandial glycemia and insulinemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteer aged 18 to 60
  • BMI between 20 and 30
  • Non-smoking
  • Using valid contraceptive method (women of childbearing age)

排除标准

  • Iodine allergy, or allergy to components of the test product or placebo or standard meal
  • Use of dietary supplements for duration of study
  • History of gastro-intestinal affections, anemia, major surgeries or surgeries of the stomach or digestive tract

研究组 & 干预措施

Brown Seaweed Lemon Tea

Experimental

Single administration of lemon tea containing 500 mg of brown seaweed powder and 50 g of sucrose

干预措施: Reduction of glycemic index of ingested foods (Dietary Supplement)

Placebo lemon tea

Placebo Comparator

Single administration of placebo lemon tea containing 50 g of sucrose

干预措施: Reduction of glycemic index of ingested foods (Dietary Supplement)

结局指标

主要结局

Significant reduction in postprandial glycemia

时间窗: Immediately after product administration (single use)

Significant reduction in postprandial insulinemia

时间窗: Immediately after product administration (single use)

次要结局

  • Frequency and severity of Adverse Events as a Measure of Safety and Tolerability(First administration up to 7 days after last administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验